Welcome to a new work week, the final couple of days of July. Here is what I'm reading this morning: The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs (Benzinga) Would AbbVie’s top execs really pull the trigger on a $30B M&A deal? Why, yes, actually (Endpoints) 7 medtech stories we missed this … Continue reading Monday Morning Healthcare News
Category: Daily Reads
Friday Morning’s Top Articles
Happy Friday! Here is what I am reading as we head into the weekend: Talk about hitting on a lot of points, super insightful article - Regeneron’s Billionaire Founder Battles The Drug Pricing System (Forbes). Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups (Xconomy) When healthcare devices go over the counter. An important … Continue reading Friday Morning’s Top Articles
Thursday Morning Headlines
Yesterday was dominated by Biogen's news on their Alzheimer drug, but there was other news including Sarepta getting slapped with a clincial hold, Gilead CEO stepping down and, although not Life Science related, Facebook getting crushed after their earnings. Here is what I'm reading: Yesterday afternoon Eisai & Biogen Revealed Promising Alzheimer’s Data But Questions … Continue reading Thursday Morning Headlines
MattCorc 